AU9059991A - Controlling beta-amyloid related neuronal degeneration by antagonizing NGF-effected neuronal activity - Google Patents

Controlling beta-amyloid related neuronal degeneration by antagonizing NGF-effected neuronal activity

Info

Publication number
AU9059991A
AU9059991A AU90599/91A AU9059991A AU9059991A AU 9059991 A AU9059991 A AU 9059991A AU 90599/91 A AU90599/91 A AU 90599/91A AU 9059991 A AU9059991 A AU 9059991A AU 9059991 A AU9059991 A AU 9059991A
Authority
AU
Australia
Prior art keywords
effected
neuronal
amyloid related
degeneration
controlling beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU90599/91A
Inventor
Bruce A Yankner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Center Corp
Original Assignee
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center Corp filed Critical Childrens Medical Center Corp
Publication of AU9059991A publication Critical patent/AU9059991A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU90599/91A 1990-11-13 1991-11-13 Controlling beta-amyloid related neuronal degeneration by antagonizing NGF-effected neuronal activity Abandoned AU9059991A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61232990A 1990-11-13 1990-11-13
US612329 1990-11-13

Publications (1)

Publication Number Publication Date
AU9059991A true AU9059991A (en) 1992-06-11

Family

ID=24452704

Family Applications (1)

Application Number Title Priority Date Filing Date
AU90599/91A Abandoned AU9059991A (en) 1990-11-13 1991-11-13 Controlling beta-amyloid related neuronal degeneration by antagonizing NGF-effected neuronal activity

Country Status (2)

Country Link
AU (1) AU9059991A (en)
WO (1) WO1992008483A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9304075A (en) * 1992-07-08 1994-04-29 Applied Research Systems PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF CONSUMPTIVE THROMBOHEMORRHAGIC DISORDERS.
US6291247B1 (en) 1994-05-11 2001-09-18 Queen's University At Kingston Methods of screening for factors that disrupt neurotrophin conformation and reduce neurotrophin biological activity
US20060141036A1 (en) 1997-12-12 2006-06-29 Andrx Labs Llc HMG-CoA reductase inhibitor extended release formulation
DE60044149D1 (en) * 1999-08-06 2010-05-20 S I S S A Scuola Internaz Supe TRANSGENIC MICE FOR STUDYING NEURODEEGENERATIVE SYNDROMES
FR2807660A1 (en) * 2000-04-13 2001-10-19 Warner Lambert Co Use of a nerve growth factor antagonist for the manufacture of a medicament for the prevention or treatment of chronic visceral pain
EP1500399A1 (en) * 2003-07-24 2005-01-26 Institut Pasteur Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative deseases
ITRM20030601A1 (en) 2003-12-24 2005-06-25 Lay Line Genomics Spa METHOD FOR THE HUMANIZATION OF HUMANIZED ANTIBODIES AND ANTIBODIES WITH IT OBTAINED.
ITRM20050290A1 (en) 2005-06-07 2006-12-08 Lay Line Genomics Spa USE OF MOLECULES ABLE TO INHIBIT THE BOND BETWEEN NGF AND ITS TRKA RECEPTOR AS AN EXTENDED EFFECT ANALGESICS.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230691A (en) * 1978-05-23 1980-10-28 The Massachusetts General Hospital Nerve growth factor antibody and process
US4701407A (en) * 1982-11-24 1987-10-20 Baylor College Of Medicine Diagnosis of Alzheimer disease
US4474892A (en) * 1983-02-16 1984-10-02 Board Of Trustees Of The Leland Stanford Junior University Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same
US4868107A (en) * 1986-11-18 1989-09-19 The United States Of America As Represented By The Department Of Health And Human Services Method for detecting antibodies against neuropeptides and drugs in human body fluid

Also Published As

Publication number Publication date
WO1992008483A1 (en) 1992-05-29

Similar Documents

Publication Publication Date Title
AU2783889A (en) Irrigation controller
AU7637694A (en) Controlled multi-pharmaceutical inhaler
AU1596888A (en) Sterol regulatory elements
AU4209197A (en) Process for the control of weeds
AU2802689A (en) Programmable control system
AU602077B2 (en) Control assembly for chair height adjustment
AU1010592A (en) Plasmids for controlling expression in plants
AU4348089A (en) Knee-tilt chair control
AU4160093A (en) Self-steering assembly
AU4719389A (en) Gain controller
AU2052188A (en) Toothbrush for controlling brushing-stroke
AU2764288A (en) Method for the control of mollusks
AU9059991A (en) Controlling beta-amyloid related neuronal degeneration by antagonizing NGF-effected neuronal activity
AU4731389A (en) Suspension adjustment
AU628720B2 (en) Control apparatus
AU3406793A (en) 2-oxoquinoline derivatives
AU5912090A (en) Method for controlling macroinvertebrates utilizing decylthioethylamine
AU580484B1 (en) Programmable controller
AU1902088A (en) Tertiary 2,5-dialkyl-3-phenylpiperidine derivatives having opiate-antagonistic activity
AU2764188A (en) Method for the control of mollusks
AU3697893A (en) Propenoyl-imidazole derivatives
AU5394794A (en) Ellipticine derivative and process for preparing the same
AU4722293A (en) Plant pot
AU7976491A (en) Special effects controller
AU3162095A (en) Piperazinothiopyridines for the control of helicobater bacteria